Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSt James's Place Regulatory News (STJ)

Share Price Information for St James's Place (STJ)

Share Price is delayed by 15 minutes
Get Live Data
1,226.50    15.00 (1.24%)
Bid:
1,227.50
Ask:
1,228.50
Spread: 1.00 (0.081%)
Market Cap: £6.24b
STJ Live PriceLast checked at - London Stock Exchange

Intraday St James's Place Share Chart

Director/PDMR Shareholding

25 Oct 2017 09:23

St. James’s Place plc (“SJP”)

SJP was notified on 24 October 2017 of the following changes in SJP shares held by the Executive Directors named below.

SJP Performance Share Plan 2005 (“PSP”) and linked Company Share Option Plan 2010 (“CSOP”)

CSOP

On 26 March 2014 the following Executive Directors (“the Directors”) were awarded a CSOP-linked award, whereby they were granted a nil-cost unapproved option pursuant to the PSP and a linked HMRC-approved CSOP share option:

Andrew Croft, Chief Financial Officer

Ian Gascoigne, Managing Director

David Lamb, Managing Director

The Directors exercised the linked CSOP award on 24 October 2017 with an exercise price of £8.515 per share and, as a result, their linked PSP awards automatically lapsed in respect of the number of shares equal in value to the gain realised upon exercise of the linked CSOP award.

Column 1 sets out the number of SJP shares acquired as a result of the exercise of the linked CSOP award on 24 October 2017, and column 2 sets out the number of SJP shares sold on 24 October 2017 at £11.81 pence per share by the Directors. Column 3 sets out the number of shares that have lapsed under the linked PSP award as a result of these exercises, and Column 4 sets out the number of PSP award shares retained under the linked PSP award.

CSOP 1 2 3 4
Name of Director Number of SJP shares acquired on exercise of CSOP option Number of SJP shares sold Number of SJP shares that have lapsed under the linked PSP award Number of SJP shares retained under the linked PSP award
Andrew Croft 3,054 3,054 853 72,312
Ian Gascoigne 3,054 2,632 853 72,312
David Lamb 3,054 3,054 853 72,312

PSP

On 26 March 2014 the Directors were awarded nil cost unapproved PSP awards. On 24 October 2017 the Directors exercised those awards, as set out in the table below.

Column 1 sets out the number of SJP shares exercised, column 2 sets out the number of SJP shares sold on 24 October 2017 at a price of £11.72 pence per share by the Directors in order to settle income tax and National Insurance liabilities, and column 3 sets out the number of additional SJP shares sold by the Directors at £11.72. Column 4 sets out the number of SJP shares retained.

PSP 1 2 3 4
Name of Director Number of SJP shares exercised Number of SJP shares sold to meet tax liability Number of Additional SJP Shares Sold Number of SJP shares retained
Andrew Croft 72,312 33,987 19,210 19,115
Ian Gascoigne 72,312 33,987 19,210 19,115
David Lamb 72,312 33,987 38,325 0

Following the above transactions, Ian Gascoigne gifted at nil cost 19,537 SJP shares to Gail Gascoigne, a Person Closely Associated with him, on 24 October 2017.

This notification is made in accordance with EU Market Abuse Regulation.

LEI: 213800M993ICXOMBCP87

Classification: 3.1 Additional regulated information required to be disclosed under the laws of a Member State

Deputy Company Secretary, Tel: +44 (0)1285 717237

25 October 2017

View source version on businesswire.com: http://www.businesswire.com/news/home/20171025005470/en/

Copyright Business Wire 2017

Date   Source Headline
3rd Aug 202010:19 amRNSTotal Voting Rights
28th Jul 20205:22 pmRNSDirector/PDMR Shareholding
28th Jul 20204:24 pmRNSHolding(s) in Company
28th Jul 20207:00 amRNSInterim Statement for the 6 Months to 30 June 2020
27th Jul 20205:07 pmRNSHolding(s) in Company
1st Jul 202010:35 amRNSTotal Voting Rights
23rd Jun 20207:00 amRNSNew business update - May 2020
8th Jun 20202:58 pmRNSHolding(s) in Company
1st Jun 20202:59 pmRNSTotal Voting Rights
27th May 20207:00 amRNSNew business update - April 2020
7th May 202012:40 pmRNSResult of AGM
1st May 202012:51 pmRNSTotal Voting Rights
30th Apr 20207:00 amRNSQ1 New Business Inflows and Dividend Update
28th Apr 20203:27 pmRNSHolding(s) in Company
27th Apr 202010:55 amRNSHolding(s) in Company
24th Apr 202010:14 amRNSHolding(s) in Company
21st Apr 202010:59 amRNSHolding(s) in Company
7th Apr 20204:07 pmRNSAnnual Report and Notice of AGM
7th Apr 20201:21 pmRNSHolding(s) in Company
6th Apr 202011:03 amRNSHolding(s) in Company
2nd Apr 20209:33 amRNSHolding(s) in Company
1st Apr 20209:38 amRNSTotal Voting Rights
30th Mar 20205:25 pmRNSDirector/PDMR Shareholding
23rd Mar 20201:12 pmRNSHolding(s) in Company
20th Mar 202010:59 amRNSAdditional Listing
2nd Mar 20209:28 amRNSTotal Voting Rights
27th Feb 20207:00 amRNSFinal Results
21st Feb 202010:15 amRNSHolding(s) in Company
11th Feb 20209:59 amRNSHolding(s) in Company
5th Feb 20202:40 pmRNSHolding(s) in Company
5th Feb 20202:11 pmRNSDirectorate Change
5th Feb 20209:59 amRNSHolding(s) in Company
3rd Feb 20205:03 pmRNSHolding(s) in Company
3rd Feb 202012:53 pmRNSBlock listing Interim Review
3rd Feb 202010:52 amRNSTotal Voting Rights
30th Jan 20207:00 amRNSQ4 New Business Inflows and Funds under Management
22nd Jan 202010:09 amRNSHolding(s) in Company
10th Jan 20204:57 pmRNSHolding(s) in Company
2nd Jan 202010:17 amRNSTotal Voting Rights
27th Dec 201911:21 amRNSHolding(s) in Company
27th Dec 20199:35 amRNSHolding(s) in Company
13th Dec 20192:47 pmRNSHolding(s) in Company
9th Dec 201910:17 amRNSHolding(s) in Company
6th Dec 201911:20 amRNSHolding(s) in Company
2nd Dec 201910:28 amRNSTotal Voting Rights
28th Nov 201910:51 amRNSHolding(s) in Company
21st Nov 20194:00 pmRNSDirectorate Change
19th Nov 20192:48 pmRNSHolding(s) in Company
1st Nov 20199:30 amRNSTotal Voting Rights
31st Oct 20194:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.